Value of ezrin, maspin and nm23-H1 protein expressions in predicting outcome of patients with head and neck squamous-cell carcinoma treated with radical radiotherapy
Published inJournal of clinical pathology, vol. 60, no. 2, p. 185-189
Publication date2007
Abstract
Keywords
- Adult
- Aged
- Aged, 80 and over
- Carcinoma, Squamous Cell/metabolism/pathology/radiotherapy
- Cytoskeletal Proteins/metabolism
- Disease-Free Survival
- Female
- Genes, Tumor Suppressor
- Head and Neck Neoplasms/metabolism/pathology/radiotherapy
- Humans
- Immunoenzyme Techniques
- Male
- Middle Aged
- NM23 Nucleoside Diphosphate Kinases
- Neoplasm Proteins/metabolism
- Nucleoside-Diphosphate Kinase/metabolism
- Prognosis
- Retrospective Studies
- Serpins/metabolism
- Treatment Outcome
- Tumor Markers, Biological/metabolism
Citation (ISO format)
MHAWECH-FAUCEGLIA, Paulette et al. Value of ezrin, maspin and nm23-H1 protein expressions in predicting outcome of patients with head and neck squamous-cell carcinoma treated with radical radiotherapy. In: Journal of clinical pathology, 2007, vol. 60, n° 2, p. 185–189. doi: 10.1136/jcp.2006.036624
Main files (1)
Article (Published version)
Identifiers
- PID : unige:25896
- DOI : 10.1136/jcp.2006.036624
- PMID : 16698950
Journal ISSN0021-9746
